dual 5-/15-lipoxygenase inhibitors (Galileo)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namedual 5-/15-lipoxygenase inhibitors (Galileo)
Drug Alias Namedual 5-LO/15-LO inhibitors (Galileo)GPI-22084
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionArachidonate 15-lipoxygenase inhibitorsArachidonate 5-lipoxygenase inhibitors
TargetsArachidonate 15-lipoxygenaseArachidonate 5-lipoxygenase
Therapy Area/IndicationsDiabetes MellitusOsteoporosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGalileo Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGalileo Pharmaceuticals
Active IndicationsN/A
Inactive IndicationsDiabetes MellitusOsteoporosis

Other Information

ATC CodeN/A
Related LinksN/A